Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.

Naing C, Mak JW, Aung K, Wong JY.

Trans R Soc Trop Med Hyg. 2013 Feb;107(2):65-73. doi: 10.1093/trstmh/trs019. Epub 2012 Dec 4. Review.

PMID:
23222952
2.

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.

Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ.

J Infect Dis. 2004 Nov 15;190(10):1773-82. Epub 2004 Oct 18. Erratum in: J Infect Dis. 2005 Apr 1;191(7):1204.

PMID:
15499533
3.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.

Naing C, Racloz V, Whittaker MA, Aung K, Reid SA, Mak JW, Tanner M.

PLoS One. 2013 Dec 3;8(12):e78819. doi: 10.1371/journal.pone.0078819. eCollection 2013. Review.

4.

Artemisinin-based combination therapy for treating uncomplicated malaria.

Sinclair D, Zani B, Donegan S, Olliaro P, Garner P.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. doi: 10.1002/14651858.CD007483.pub2. Review.

PMID:
19588433
5.

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.

Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D.

Cochrane Database Syst Rev. 2014 Jan 20;(1):CD010927. doi: 10.1002/14651858.CD010927. Review.

6.

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.

Gargano N, Ubben D, Tommasini S, Bacchieri A, Corsi M, Bhattacharyya PC, Rao BH, Dubashi N, Dev V, Ghosh SK, Kumar A, Srivastava B, Valecha N.

Malar J. 2012 Jul 20;11:233. doi: 10.1186/1475-2875-11-233.

7.

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.

Keating GM.

Drugs. 2012 May 7;72(7):937-61. doi: 10.2165/11203910-000000000-00000. Review.

PMID:
22515619
8.

Azithromycin for treating uncomplicated malaria.

van Eijk AM, Terlouw DJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006688. doi: 10.1002/14651858.CD006688.pub2. Review.

PMID:
21328286
9.

Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.

Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Séré Y, Rosenthal PJ, Ouédraogo JB.

Clin Infect Dis. 2007 Dec 1;45(11):1453-61. Epub 2007 Oct 22.

PMID:
17990228
10.

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P.

Antimicrob Agents Chemother. 2013 Feb;57(2):818-26. doi: 10.1128/AAC.00686-12. Epub 2012 Dec 3.

11.
12.

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.

Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, Janssens B, Mayxay M, Newton P, Singhasivanon P, Stepniewska K, White NJ, Nosten F.

PLoS One. 2009 Jul 29;4(7):e6358. doi: 10.1371/journal.pone.0006358.

13.

Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.

Sinclair D, Gogtay N, Brand F, Olliaro P.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008492. doi: 10.1002/14651858.CD008492.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD008492.

PMID:
21735431
14.

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.

Ashley EA, McGready R, Hutagalung R, Phaiphun L, Slight T, Proux S, Thwai KL, Barends M, Looareesuwan S, White NJ, Nosten F.

Clin Infect Dis. 2005 Aug 15;41(4):425-32. Epub 2005 Jul 15.

PMID:
16028147
15.

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.

Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J.

Lancet. 2004 Jan 3;363(9402):18-22.

PMID:
14723988
16.

Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties.

Gargano N, Cenci F, Bassat Q.

Trop Med Int Health. 2011 Dec;16(12):1466-73. doi: 10.1111/j.1365-3156.2011.02855.x. Epub 2011 Sep 13. Review.

17.

A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.

Janssens B, van Herp M, Goubert L, Chan S, Uong S, Nong S, Socheat D, Brockman A, Ashley EA, Van Damme W.

Trop Med Int Health. 2007 Feb;12(2):251-9.

18.

Artemisinin derivatives and malaria: useful, in combination with other antimalarials.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):162-8.

PMID:
19492494
19.

Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.

Menan H, Faye O, Same-Ekobo A, Oga AS, Faye B, Kiki Barro CP, Kuete T, N'diaye JL, Vicky AM, Tine R, Yavo W, Kane D, Kassi KF, Kone M.

Malar J. 2011 Jul 8;10:185. doi: 10.1186/1475-2875-10-185.

20.

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).

Mayxay M, Thongpraseuth V, Khanthavong M, Lindegårdh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K, White NJ, Newton PN.

Trop Med Int Health. 2006 Aug;11(8):1157-65.

Supplemental Content

Support Center